Association of botulinum neurotoxins with synaptic vesicle protein complexes

Toxicon

Volumn 54, Issue 5, 2009, Pages 570-574

  Baldwin, Michael R ^a   Barbieri, Joseph T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Botulinum neurotoxins; SV2; Synaptotagmin; VAMP 2

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; CALCIUM ION; GANGLIOSIDE GD 1A; GANGLIOSIDE GT 1B; MEMBRANE PROTEIN; METALLOPROTEINASE; PHOSPHOPROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SNARE PROTEIN; SYNAPTIC VESICLE PROTEIN 2; SYNAPTOBREVIN 2; SYNAPTOGYRIN 1; SYNAPTOGYRIN 3; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 2; ZINC METALLOPROTEINASE;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CALCIUM TRANSPORT; COMPLEX FORMATION; DENSITY GRADIENT; ENDOCYTOSIS; ENZYME SUBSTRATE COMPLEX; MASS SPECTROMETRY; MEMBRANE BINDING; NEUROTOXICITY; NEUROTOXICOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; TOXIN ANALYSIS; TOXIN STRUCTURE;

ANIMALS; BOTULINUM TOXINS; HUMANS; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; NEUROTOXINS; PROTEIN BINDING; SNARE PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTIC VESICLES;

CLOSTRIDIA;

EID: 68949167926     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.01.040     Document Type: Article

References (45)

1. Baldwin M.R., and Barbieri J.T. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry 46 (2007) 3200-3210
2. Belizaire R., Komanduri C., Wooten K., Chen M., Thaller C., and Janz R. Characterization of synaptogyrin 3 as a new synaptic vesicle protein. J. Comp. Neurol. 470 (2004) 266-281
3. Bennett M.K., Calakos N., Kreiner T., and Scheller R.H. Synaptic vesicle membrane proteins interact to form a multimeric complex. J. Cell. Biol. 116 (1992) 761-775
4. Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T.C., Niemann H., and Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365 (1993) 160-163
5. Blasi J., Chapman E.R., Yamasaki S., Binz T., Niemann H., and Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12 (1993) 4821-4828
6. Breidenbach M.A., and Brunger A.T. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432 (2004) 925-929
7. Bullens R.W., O'Hanlon G.M., Wagner E., Molenaar P.C., Furukawa K., Plomp J.J., and Willison H.J. Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J. Neurosci. 22 (2002) 6876-6884
8. Bullens R.W., O'Hanlon G.M., Wagner E., Molenaar P.C., Furukawa K., Plomp J.J., and Willison H.J. Roles of complex gangliosides at the neuromuscular junction. Ann. N.Y. Acad. Sci. 998 (2003) 401-403
9. Chen S., and Barbieri J.T. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J. Biol. Chem. 282 (2007) 25540-25547
10. DasGupta B.R., and Dekleva M.L. Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site. Biochimie 72 (1990) 661-664
11. Dong M., Richards D.A., Goodnough M.C., Tepp W.H., Johnson E.A., and Chapman E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162 (2003) 1293-1303
12. Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., and Chapman E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science (2006)
13. Galli T., McPherson P.S., and De Camilli P. The V0 sector of the V-ATPase, synaptobrevin, and synaptophysin are associated on synaptic vesicles in a Triton X-100-resistant, freeze-thawing sensitive, complex. J. Biol. Chem. 271 (1996) 2193-2198
14. Hioki H., Fujiyama F., Taki K., Tomioka R., Furuta T., Tamamaki N., and Kaneko T. Differential distribution of vesicular glutamate transporters in the rat cerebellar cortex. Neuroscience 117 (2003) 1-6
15. Hjelmeland L.M., and Chrambach A. Solubilization of functional membrane proteins. Methods Enzymol. 104 (1984) 305-318
16. Johnson E.A., and Bradshaw M. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon 39 (2001) 1703-1722
17. Kaneko T., Fujiyama F., and Hioki H. Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain. J. Comp. Neurol. 444 (2002) 39-62
18. Khvotchev M.V., and Sudhof T.C. Stimulus-dependent dynamic homo- and heteromultimerization of synaptobrevin/VAMP and synaptophysin. Biochemistry 43 (2004) 15037-15043
19. Kitamura M., Takamiya K., Aizawa S., and Furukawa K. Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. Biochim. Biophys. Acta 1441 (1999) 1-3
20. Koriazova L.K., and Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 10 (2003) 13-18
21. Kozaki S., Kamata Y., Watarai S., Nishiki T., and Mochida S. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb. Pathog. 25 (1998) 91-99
22. Lacy D.B., and Stevens R.C. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291 (1999) 1091-1104
23. Lacy D.B., Tepp W., Cohen A.C., DasGupta B.R., and Stevens R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5 (1998) 898-902
24. Lalli G., Herreros J., Osborne S.L., Montecucco C., Rossetto O., and Schiavo G. Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell Sci. 112 Pt 16 (1999) 2715-2724
25. Lomneth R., Gimenez J., Martin T.F., and DasGupta B.R. Calcium-dependent release of norepinephrine from permeabilized PC12 cells is inhibited by approximately 48 and approximately 112 kDa fragments of botulinum neurotoxin type E. Neuropharmacology 32 (1993) 285-289
26. Mahrhold S., Rummel A., Bigalke H., Davletov B., and Binz T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 580 (2006) 2011-2014
27. Montecucco C., Rossetto O., and Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 12 (2004) 442-446
28. Nakamura K., Hioki H., Fujiyama F., and Kaneko T. Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J. Comp. Neurol. 492 (2005) 263-288
29. Nishiki T., Kamata Y., Nemoto Y., Omori A., Ito T., Takahashi M., and Kozaki S. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269 (1994) 10498-10503
30. Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sato K., Sekiguchi M., Takahashi M., and Kozaki S. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 378 (1996) 253-257
31. Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sekiguchi M., Takahashi M., and Kozaki S. Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci. Lett. 208 (1996) 105-108
32. Ochanda J.O., Syuto B., Ohishi I., Naiki M., and Kubo S. Binding of Clostridium botulinum neurotoxin to gangliosides. J. Biochem. (Tokyo) 100 (1986) 27-33
33. Poea-Guyon S., Amar M., Fossier P., and Morel N. Alternative splicing controls neuronal expression of v-ATPase subunit a1 and sorting to nerve terminals. J. Biol. Chem. 281 (2006) 17164-17172
34. Rummel A., Karnath T., Henke T., Bigalke H., and Binz T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279 (2004) 30865-30870
35. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., DasGupta B.R., and Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359 (1992) 832-835
36. Schiavo G., Malizio C., Trimble W.S., Polverino de Laureto P., Milan G., Sugiyama H., Johnson E.A., and Montecucco C. Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J. Biol. Chem. 269 (1994) 20213-20216
37. Schiavo G., Shone C.C., Rossetto O., Alexander F.C., and Montecucco C. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268 (1993) 11516-11519
38. Schivell A.E., Batchelor R.H., and Bajjalieh S.M. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin. J. Biol. Chem. 271 (1996) 27770-27775
39. Schivell A.E., Mochida S., Kensel-Hammes P., Custer K.L., and Bajjalieh S.M. SV2A and SV2C contain a unique synaptotagmin-binding site. Mol. Cell Neurosci. 29 (2005) 56-64
40. Shapiro R.L., Hatheway C., Becher J., and Swerdlow D.L. Botulism surveillance and emergency response. A public health strategy for a global challenge. JAMA 278 (1997) 433-435
41. Smith T.J., Lou J., Geren I.N., Forsyth C.M., Tsai R., Laporte S.L., Tepp W.H., Bradshaw M., Johnson E.A., Smith L.A., and Marks J.D. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 73 (2005) 5450-5457
42. Sobel J. Botulism. Clin. Infect. Dis. 41 (2005) 1167-1173
43. Stenius K., Janz R., Sudhof T.C., and Jahn R. Structure of synaptogyrin (p29) defines novel synaptic vesicle protein. J. Cell. Biol. 131 (1995) 1801-1809
44. Ullrich B., and Sudhof T.C. Differential distributions of novel synaptotagmins: comparison to synapsins. Neuropharmacology 34 (1995) 1371-1377
45. Yelamanchili S.V., Reisinger C., Becher A., Sikorra S., Bigalke H., Binz T., and Ahnert-Hilger G. The C-terminal transmembrane region of synaptobrevin binds synaptophysin from adult synaptic vesicles. Eur. J. Cell Biol. 84 (2005) 467-475